Lohmann Rauscher, Inc.

Synthes Usa, LLC

Xylos Corporation

Synthes Gmbh

Synthes USA Products, LLC

Gerry Ann Oster

Gonzalo Serafica

Richard Paul Mormino

Kevin E Lentz

Kevin P Koehler

Christopher James Damien

Heather Ann Beam

Frederic S Wright

Frederick S Wright

Russell Hoon

Kevin Koehler

A thermally modified microbial-derived cellulose material is described for use as an implantable material in general surgery, plastic surgery and neurosurgery.

Thermally modified microbial-derived cellulose for in vivo implantation

The invention relates to a wound dressing comprising a microbial-derived cellulose for treatment of specific types of chronic wounds, including pressure sores, venous and diabetic ulcers. The wound dressing is capable of donating liquid to dry substrates is also capable of absorbing exudating wounds.

Microbial cellulose wound dressing for treating chronic wounds

The invention relates to a wound dressing comprising a microbial-derived cellulose for treatment of specific types of chronic wounds, including pressure sores, venous and diabetic ulcers. The wound dressing is capable of donating liquid to dry substances is also capable of absorbing exudating wounds.

The invention relates to dura substitutes to be used as prostheses for dural defects in the field of neurosurgery and processes for producing the same. The present invention provides artificial dura mater materials comprising sheets of microbial-derived polysaccharide processed to have the necessary strength characteristics, conformability and physical properties.

Process for producing a dura substitute

Dura substitute and a process for producing the same

A solvent dehydrated microbially-derived cellulose material is described for use as an implantable material in general and plastic surgery.

Solvent dehydrated microbially-derived cellulose for in vivo implantation

Growing community of inventors

Langhorne, PA, United States of America

Gerry Ann Oster